May 2, 2024, 2:10 PM
Apr 29, 2024, 7:35 PM
Eli Lilly's GLP-1 Revenue Surges and Raises Future Guidance
- Eli Lilly reports $2 billion revenue from GLP-1s in Q1.
- The expanded use of GLP-1s could impact long-term outlooks for Eli Lilly and Novo Nordisk.
- Eli Lilly raises FY 2024 guidance based on successful sales of GLP-1 drugs.
Opinions
You've reached the end